CENTER VALLEY, Pa., May 28, 2025 /PRNewswire/ — Aesculap, Inc. (Aesculap), an industry leader in sterile processing and operating room solutions, is pleased to announce the extension of its partnership with Ascendco Health, an innovative health tech company, for another ten years. The partnership, which began five years ago, aims to transform perioperative workflows by combining Aesculap’s industry-leading expertise in surgical instrumentation and sterile processing with Ascendco Health’s proprietary asset management technology.
By extending the partnership, both companies reaffirm their commitment to delivering the most comprehensive software solution for surgical asset management, quality, staffing, regulatory compliance and real-time inventory visibility. This continued collaboration will further enable health systems to drive operational efficiency, reduce waste, enhance patient care and improve overall perioperative performance.
“The progress we’ve made together demonstrates the strength of our partnership and the power of joining Aesculap’s sterile processing capabilities with Ascendco Health’s data-driven technology,” said Bob Sowinski, Corporate Vice President, Aesculap, Inc. “This extension allows us to continue driving measurable improvements in perioperative efficiency and broaden the scope and impact of our solutions, creating lasting value for our customers and the patients they serve.”
To date, the partnership has driven improvements for more than 200 healthcare facilities by helping optimize surgical workflows, reduce operational costs and improve the overall delivery of patient care. By combining Aesculap’s proven track record in surgical asset management with Ascendco Health’s data visualization and analytics capabilities, the companies have provided health systems with the tools needed to make informed decisions, streamline operations and drive continuous improvement in perioperative processes.
Brian Reed, CEO of Ascendco Health, commented, “This partnership drives innovation and connectivity between Aesculap and hospitals, with Ascendco Health’s analytics at the core, to transform care delivery and maximize impact on surgical efficiency and resource utilization. We are pleased to continue supporting Aesculap’s ability to deliver smarter, data-driven solutions that enhance value for its customers.”
For more information, please visit our website.
About Aesculap, Inc.
Aesculap, Inc., a B. Braun company, is part of a 180-year-old global organization focused on meeting the needs of an ever-changing healthcare community. Through close collaboration with its customers, Aesculap provides advanced technologies for neurosurgery, general surgery and sterilization technologies. Aesculap continues a proud heritage of leadership and responsiveness as we strive to deliver products and services that improve the quality of patients’ lives. For more information, call 800-282-9000 or visit aesculapusa.com.
SOURCE Aesculap, Inc.
– Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI)…
D-bal-max D-Bal MAX Glasgow, June 15, 2025 (GLOBE NEWSWIRE) -- In the quest for enhanced…
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment…
Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response…
After a thorough clinical review, the benefit-risk for the use of Elevidys in non-ambulatory patients…
77% of patients (150 mg Q4W) treated with barzolvolimab who had angioedema at baseline were…